Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;146(12):1593-1601.
doi: 10.1017/S0950268818001619. Epub 2018 Jun 18.

Seroepidemiology of varicella zoster virus infection in Vojvodina, Serbia

Affiliations

Seroepidemiology of varicella zoster virus infection in Vojvodina, Serbia

S Medić et al. Epidemiol Infect. 2018 Sep.

Abstract

The present cross-sectional serosurvey constitutes the first effort to describe the varicella zoster virus (VZV) seroepidemiology in Serbia. An age-stratified serum bank of 3570 residual samples collected between 2015 and 2016 in each of the seven districts of the Vojvodina Province was tested for IgG anti-VZV antibodies with an enzyme immunoassay. Results were standardised into common units according to the European Sero-Epidemiology Network (ESEN2) methodology. Univariable and multivariable analyses were used to examine the relationships between standardised anti-VZV positivity or logarithmically transformed antibody titres and demographic features of study subjects. Seropositivity (85% overall) increased with age, in parallel with geometric mean titres. By the time of school entry, 68% of children were immune. The slower subsequent acquisition of immunity leaves epidemiologically relevant proportions of adolescents (7%), young adults (6%) and especially females of reproductive age (6%) prone to more severe forms of varicella. In the ongoing pre-vaccine era, natural infection provides a high level of collective immunity, with the highest VZV transmission in children of preschool age. The detected gaps in VZV immunity of the Serbian population support the adoption of the official recommendations for varicella immunisation of non-immune adolescents and young adults, including non-pregnant women of childbearing age.

Keywords: Antibodies to varicella zoster virus (anti-VZV); ESEN2; Europe; chickenpox; seroprevalence; standardisation; vaccines and immunisation.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1.
Fig. 1.
Sera collection locations at health care institutions in each of the seven districts of the Autonomous Province of Vojvodina, Serbia, 2015–16. The province was divided into three main areas for the purposes of this survey: (a) Northern Vojvodina that included the districts of West Bačka, North Bačka and North Banat; (b) Central Vojvodina that included South Bačka and Central Banat and (c) Southern Vojvodina that included Srem county and South Banat.
Fig. 2.
Fig. 2.
Anti-VZV ELISA results of the standardisation panel obtained by Serbia (y-axis) plotted against the corresponding results of the reference laboratory (Spain, x-axis) on the logarithmic (base 10) scale. Dotted lines show the equivocal ranges (negative/positive cut-off values), while the solid line represents the quadratic regression model. The only outlier is shown in green.
Fig. 3.
Fig. 3.
Age-specific standardised seroprevalence of VZV with 95% CIs, in Vojvodina, Serbia, 2015–16.
Fig. 4.
Fig. 4.
Anti-VZV antibody titres given as geometric mean titres (GMT) expressed in standardised ESEN2 units IU/ml, according to age (a) and according to age and gender (b), in the 3570 study subjects aged 29 days–83 years from Vojvodina, Serbia; 95% CIs are also displayed. The dashed lines indicate the cut-off for positive results (0.05 IU/ml).

Similar articles

Cited by

References

    1. Gershon AA and Gershon MD (2013) Pathogenesis and current approaches to control of varicella-zoster virus infections. Clinical Microbiology Reviews 26, 728–743. - PMC - PubMed
    1. World Health Organization (2014) Varicella and herpes zoster vaccines: WHO position paper, June 2014. The Weekly Epidemiological Record 89, 265–288.
    1. Bonanni P et al. (2009) Varicella vaccination in Europe – taking the practical approach. BMC Medicine 7, 26. - PMC - PubMed
    1. Helmuth IG et al. (2015) Varicella in Europe – a review of the epidemiology and experience with vaccination. Vaccine 33, 2406–2413. - PubMed
    1. European Centre for Disease Prevention and Control (2015) Varicella Vaccination in the European Union. Stockholm: ECDC, Available at http://ecdc.europa.eu/en/publications/Publications/Varicella-Guidance-20... (Accessed 15 December 2016).

Publication types

LinkOut - more resources